Cargando…
Boosting NAD(+) blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes
BACKGROUND: Fasting and NAD(+)-boosting compounds, including NAD(+) precursor nicotinamide riboside (NR), confer antiinflammatory effects. However, the underlying mechanisms and therapeutic potential are incompletely defined. METHODS: We explored the underlying biology in myeloid cells from healthy...
Autores principales: | Wu, Jing, Singh, Komudi, Lin, Amy, Meadows, Allison M., Wu, Kaiyuan, Shing, Vivian, Bley, Maximilian, Hassanzadeh, Shahin, Huffstutler, Rebecca D., Schmidt, Mark S., Blanco, Luz P., Tian, Rong, Brenner, Charles, Pirooznia, Mehdi, Kaplan, Mariana J., Sack, Michael N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884917/ https://www.ncbi.nlm.nih.gov/pubmed/35025762 http://dx.doi.org/10.1172/JCI139828 |
Ejemplares similares
-
Boosting NAD preferentially blunts Th17 inflammation via arginine biosynthesis and redox control in healthy and psoriasis subjects
por: Han, Kim, et al.
Publicado: (2023) -
Fasting-induced FOXO4 blunts human CD4(+) T helper cell responsiveness
por: Han, Kim, et al.
Publicado: (2021) -
Identification and Validation of Nutrient State-Dependent Serum Protein Mediators of Human CD4(+) T Cell Responsiveness
por: Han, Kim, et al.
Publicado: (2021) -
Network Analysis and Transcriptome Profiling Identify Autophagic and Mitochondrial Dysfunctions in SARS-CoV-2 Infection
por: Singh, Komudi, et al.
Publicado: (2021) -
Bacteria boost host NAD metabolism
por: Shats, Igor, et al.
Publicado: (2020)